Inventiva reports preliminary 2025 fiscal year financial results
Cash and cash equivalents at €99.3 million, and €131.6 million in short-term…
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million…
Netcore’s Financial Services Trends 2026: Agentic Marketing Marks the Next Growth Shift for Financial Services in India
Financial Services Trends 2026: After a Flat 2025, Financial Services Eye 2X Revenue…
Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces…
Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026
Exceeding latest 2025 guidance following a strong performance from both commercial arms…
Quora Survey Reveals How Indians Research, Compare, and Decide on Financial Products
38% of Quora users were influenced to make a financial decision after reading…
Ferrero Group reports Consolidated Financial Statements for the 2024/2025 Financial Year
Ferrero Group maintains its growth trajectory with a 4.6% increase in turnover…
Coloplast A/S – Interim Financial Report, Q1 2025/26
2025/26Interim financial results, Q1 2025/261 October 2025 - 31 December 2025 Coloplast…
BioCryst to Report Fourth Quarter 2025 Financial Results on February 26
February 05, 2026 07:01 ET | Source: BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE…
ChipMOS Schedules Fourth Quarter and Full Year 2025 Financial Results Conference Call
February 04, 2026 05:00 ET | Source: ChipMOS TECHNOLOGIES INC. HSINCHU, Taiwan,…
